Expression profiling on chronically rejected transplant kidneys

Transplantation

Volumn 76, Issue 3, 2003, Pages 539-547

  Donauer, Johannes ^a   Rumberger, Brigitta ^a   Klein, Marinella ^a   Faller, Daniel ^b   Wilpert, Jochen ^a   Sparna, Titus ^a   Schieren, Gisela ^a   Rohrbach, Rolf ^a   Dern, Peter ^a   Timmer, Jens ^b   Pisarski, Przemyslaw ^a   Kirste, Gunter ^a   Walz, Gerd ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL ADHESION; CELL METABOLISM; CELL TRANSPORT; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETIC HETEROGENEITY; GRAFT SURVIVAL; HISTOLOGY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SURVIVAL RATE; TRANSCRIPTION INITIATION; UNINDEXED SEQUENCE;

ADULT; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYCYSTIC KIDNEY DISEASES; POSTOPERATIVE COMPLICATIONS;

EID: 0042968636     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000079459.89608.B7     Document Type: Article

References (30)

1. Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet 1999; 353(9158): 1083.
2. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342(9): 605.
3. Kahan BD. Sirolimus: a comprehensive review. Expert Opin Pharmacother 2001; 2(11): 1903.
4. Kahan BD. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction. Transplantation 2001; 71(11 Suppl): SS52.
5. Colvin RB. The renal allograft biopsy. Kidney Int 1996; 50(3): 1069.
6. Seron D, Moreso F, Fulladosa X, et al. Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int 2002; 61(2): 727.
7. Waaga AM, Gasser M, Laskowski I, et al. Mechanisms ofchronic rejection. Curr Opin Immunol 2000; 12(5): 517.
8. Jindal RM, Hariharan S. Chronic rejection in kidney transplants. An in-depth review. Nephron 1999; 83(1): 13.
9. Vazquez MA. Chronic rejection of renal transplants: new clinical insights. Am J Med Sci 2000; 320(1): 43.
10. Hariharan S. Long-term kidney transplant survival. Am J Kidney Dis 2001; 38(Suppl 6): S44.
11. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10(1): 167.
12. Regele H, Bohmig GA, Habicht A, et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13(9): 2371.
13. Paul LC. Glomerular hypertension - an under-appreciated aspect of chronic rejection. Nephrol Dial Transplant 2001; 16(2): 213.
14. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation 1998; 66(12): 1736.
15. Di Paolo S, Stallone G, Schena A, et al. Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions. Transplantation 2002; 73(4): 623.
16. Prommool S, Jhangri GS, Cockfield SM, et al. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 2000; 11(3): 565.
17. Halloran PF. Call for revolution: a new approach to describing allograft deterioration. Am J Transplant 2002; 2(3): 195.
18. Eisen MB, Brown PO. DNA arrays for analysis of gene expression. Methods Enzymol 1999; 303: 179.
19. Boldrick JC, Alizadeh AA, Diehn M, et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc Natl Acad Sci U S A 2002; 99(2): 972.
20. Dudoit S, Young YH, Speed T, et al. Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Statistica Sinica 2002; 12: 111.
21. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 1995; 57(1): 289.
22. Fellstrom B, Backman U, Larsson E, et al. Immunologic and nonimmunologic risk factors of chronic rejection. Transplant Proc 1999; 31(1-2): 1304.
23. Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999; 56(3): 783.
24. van Saase JL, van der Woude FJ, Thorogood J, et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995; 59(9): 1280.
25. Hayry P, Aavik E, Savolainen H. Mechanisms of chronic rejection. Transplant Proc 1999; 31(7A): 5S.
26. Akyurek LM, Johnsson C, Lange D, et al. Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis. J Clin Invest 1998; 101(12): 2889.
27. Fellstrom B, Backman U, Larsson E, et al. Are there markers to initiate treatment of chronic rejection? Transplant Proc 1999; 31(4): 1796.
28. Baboolal K, Jones GA, Janezic A, et al. Molecular and structural consequences of early renal allograft injury. Kidney Int 2002; 61(2): 686.
29. Nicholson ML, Waller JR, Bicknell GR. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA. Br J Surg 2002; 89(7): 933.
30. Lahlou A, Peraldi MN, Thervet E, et al. Chronic graft dysfunction in renal transplant patients: potential role of plasminogen activator inhibitor type 1. Transplantation 2002; 73(8): 1290.